中东和非洲尿液分析市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

中东和非洲尿液分析市场 – 行业趋势和 2030 年预测

  • Medical Devices
  • Upcoming Report
  • Jan 2023
  • MEA
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Middle East And Africa Urinalysis Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 183.24 Billion
Diagram Market Size (Forecast Year)
USD 252.71 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

中东和非洲尿液分析市场,按测试类型(尿液生化测试、尿液生化测试)、产品(仪器、消耗品)、测试类型(生化、怀孕和生育、沉淀物)、方式(便携式、独立式、台式、台式、其他)、应用(疾病筛查、尿路感染、肾脏疾病、糖尿病、肝脏疾病、怀孕和生育、其他)、最终用户(医院、实验室、家庭护理环境、其他)、分销渠道(直接招标、零售销售)– 行业趋势和预测到 2030 年。

中东和非洲尿液分析市场

中东和非洲尿液分析市场分析及规模

新技术的进步正在改变和改善尿液分析检测方案。主要市场参与者也在采取措施推出利用技术来推进诊断的高度自动化仪器。因此,这些正在推动尿液分析市场的发展。发达国家和发展中国家老年人口的增长推动了尿液分析市场的发展。在预测期内,新技术的发展为尿液分析市场参与者创造了无数机会。

Data Bridge Market Research 分析,2022 年尿液分析市场规模为 1.8324 亿美元,预计到 2030 年将达到 2.5271 亿美元,2023 年至 2030 年预测期内的复合年增长率为 4.1%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

中东和非洲尿液分析市场范围和细分      

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

检测类型(尿液生化检测、尿液生化检测)、产品(仪器、耗材)、方式(便携式、独立式、台式、台式、其他)、应用(尿路感染、肾病、糖尿病、肝病、妊娠及生育、其他)、最终用户(医院、实验室、家庭护理环境、其他)、分销渠道(直接招标、零售)

覆盖国家

沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 其他地区(作为中东和非洲 (MEA) 的一部分)

涵盖的市场参与者

Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (U.S.), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Quidel Corporation (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), EKF Diagnostics (U.K.), Thermo Fisher Scientific Inc. (U.S.), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (U.K.), Alphatech Scientitfic E.I.R.L (Peru), Teco Diagnostics (U.S.), Analyticon Biotechnologies GmbH (Germany)

Market Opportunities

  • Rise in significant investments

Market Definition

A urine analysis is a test used to examine the urine. A urine test can be used to help diagnose diseases because the body excretes toxins and extra fluid in the form of urine. Urine testing can be used to diagnose kidney disease and other illnesses. It entails examining urine samples for specific physical characteristics such as solutes, cells, casts, crystals, organisms, or particle debris.

Middle East and Africa Urinalysis Market Dynamics

Drivers

  • Increase in age-associated diseases

The ageing population in both developed and developing countries will benefit the urinalysis market. Diabetes, liver and kidney disease, and other age-related illnesses are expected to become more common as the senior population grows rapidly. Increased prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin have resulted from the diagnosis and treatment of such conditions. This market is expected to benefit because urinalysis is used to perform these tests.

  • Rising geriatric population

The global urinalysis market is being driven by the growing geriatric population in both developed and developing countries. Furthermore, the market is growing as a result of the rise in chronic disease prevalence and the adoption of point-of-care diagnostics. Furthermore, working people's desk-bound lifestyles contribute to a general lack of good health in many areas, fueling demand for better diagnostics such as urinalysis. As a result, rising demand for routine health checks is propelling the market forward.

Opportunities

  • Rise in significant investments

The high disease prevalence, large patient population, expanding medical tourism, improving healthcare infrastructure, and rising disposable income in these countries. As the markets in the Middle East and Africa mature, the majority of players are shifting their attention to emerging markets. Upgrading laboratory infrastructure in emerging markets is critically dependent on significant investments in healthcare and life sciences research in these countries. As a result, the urinalysis market expands and encourages the installation of diagnostic equipment in laboratories.

Restraints/Challenges

  • Unfavourable reimbursement scenario

The availability of refurbished instruments, which perform the same functions as new equipment but at a lower cost, poses a threat to the growth of the sector. The lack of strong regulatory frameworks may result in increased consumption of used goods in the economy.

This urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Urinalysis Market

With the COVID-19 pandemic, there is an increased need for more accurate and user-friendly testing technologies, as well as testing infrastructure expansion, in addition to the development of vaccines and therapeutic medications. Governments and healthcare providers are facing unprecedented challenges as a result of COVID-19, which impacted the regulatory environment and procedures. Regulatory authorities used methods to expedite diagnostic product approval. Businesses have made strategic moves to implement COVID-19 rapid testing, maintain revenues, and mitigate the impact of COVID-19 on their operational capacities.

Recent Development

  • In 2020, DIRUI announced the signing of an agreement with Changchun Center Hospital to construct a laboratory for high-quality IVD product manufacturing. This decision aided in the testing process's implications reduced repeated examinations and reduced the cost of diagnosis. Over time, this will result in significant growth for the company.

Middle East and Africa Urinalysis Market Scope

The urinalysis market is segmented on the basis of testing type, product, modality, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Testing Type

  • Urine Biochemistry Testing
  • Urine Biochemistry Testing

 Product

  • Instruments
  • Biochemical Urine Analyzers
  • Automated biochemical analyzers
  • Semi-automated Biochemical Analyzers
  • Automated Urine Sediment Analyzers
  • Microscopic Urine Analyzers
  • Flow-Cytometric Urine Analyzers
  • Point-Of-Care Urine Analyzers
  • Consumables
  • Dipsticks
  • Reagents
  • Disposables
  • Pregnancy and Fertility Kits

Modality

  • Portable
  • Standalone
  • Table Top
  • Bench Top
  • Others

 Application

  • Urinary Tract Infections
  • Kidney Diseases
  • Diabetes
  • Liver Diseases
  • Pregnancy and Fertility
  • Others

 End User

  • Hospital
  • Laboratory
  • Home Care Settings
  • Others

 Distribution Channel

  • Direct Tender
  • Retail Sales

尿液分析市场区域分析/见解

对尿液分析市场进行了分析,并按国家、测试类型、产品、方式、应用和最终用户提供了市场规模洞察和趋势。

尿液分析市场报告涵盖的国家包括沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲(MEA)其他地区。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和尿液分析市场份额分析

尿液分析市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对尿液分析市场的关注有关。

尿液分析市场的一些主要参与者包括:

  • 西门子(德国)
  • F. Hoffmann-La Roche Ltd.(瑞士)
  • 康德乐 (美国)
  • 雅培(美国)
  • 丹纳赫(美国)
  • Sysmex 公司 (日本)
  • Quidel Corporation(美国)
  • BD(美国)
  • Bio-Rad Laboratories, Inc.(美国)
  • EKF 诊断(英国)
  • 赛默飞世尔科技公司(美国)
  • ARKRAY 株式会社(日本)
  • ACON Laboratories, Inc.(美国)
  • 77 Elektronika Kft.(匈牙利)
  • 优利特医疗电子集团有限公司 (中国)
  • 迪瑞实业股份有限公司 (中国)
  • 深圳迈瑞生物医疗电子股份有限公司 (中国)
  • BIOBASE集团(中国)
  • ERBA 曼海姆(英国)
  • Alphatech Scientitfic EIRL(秘鲁)
  • Teco Diagnostics(美国)
  • Analyticon Biotechnologies GmbH(德国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Middle East and Africa urinalysis market size will be worth
The growth rate of the Middle East and Africa urinalysis market is 4.1% in the forecast period by 2030.
Testing type, product, modality, application, and end-user are the factors on which the Middle East and Africa urinalysis market research is based.
An increase in age-associated diseases & the rising geriatric population are the growth drivers of the Middle East and Africa urinalysis market.
Major companies in the Middle East and Africa urinalysis market are Siemens (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health (U.S.), Abbott (U.S.), Danaher (U.S.), Sysmex Corporation (Japan), Quidel Corporation (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), EKF Diagnostics (U.K.), Thermo Fisher Scientific Inc. (U.S.), ARKRAY, Inc. (Japan), ACON Laboratories, Inc. (U.S.), 77 Elektronika Kft. (Hungary), URIT Medical Electronic Group Co., Ltd. (China), Dirui Industrial Co., Ltd. (China), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), BIOBASE Group (China), ERBA Mannheim (U.K.), Alphatech Scientitfic E.I.R.L (Peru), Teco Diagnostics (U.S.), Analyticon Biotechnologies GmbH (Germany)